MET 📈 MetLife - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US59156R1086

MET: Insurance, Annuities, Employee Benefits, Asset Management

MetLife, Inc. is a multinational financial services company that offers a wide range of insurance, annuities, and asset management services to individuals, corporations, and institutions worldwide. The company's operations are divided into six distinct segments, including Retirement and Income Solutions, Group Benefits, Asia, Latin America, Europe, the Middle East and Africa, and MetLife Holdings, each catering to specific markets and customer needs. Through these segments, MetLife provides an extensive array of products, including life, dental, disability, and accident insurance, as well as annuities, pension products, and investment solutions.

The company's product portfolio is diverse and comprehensive, featuring various types of insurance coverages, such as group short-and long-term disability, individual disability, pet insurance, and accidental death and dismemberment insurance. Additionally, MetLife offers administrative services-only arrangements to employers, general and separate account contracts, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. Its pension risk transfer solutions, institutional income annuities, and structured settlements are designed to help institutions and individuals manage their retirement and financial risks. Furthermore, MetLife provides fixed, indexed-linked, and variable annuities, whole and term life insurance, and longevity reinsurance solutions to address the complex needs of its customers.

MetLife's operations are supported by its global presence, with a significant footprint in key markets across Asia, Latin America, Europe, the Middle East, and Africa. The company's commitment to innovation and customer satisfaction has enabled it to maintain a strong position in the global insurance and financial services industry. With a history dating back to 1999, MetLife, Inc. is headquartered in New York, New York, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol MET. The company's common stock is classified under the GICS Sub Industry: Life & Health Insurance, and its ISIN is US59156R1086. For more information, investors and customers can visit the company's website at https://www.metlife.com.

Additional Sources for MET Stock

MET Stock Overview

Market Cap in USD 57,464m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2000-04-05

MET Stock Ratings

Growth 5y 71.5%
Fundamental 35.1%
Dividend 43.0%
Rel. Strength Industry -13
Analysts 4.2/5
Fair Price Momentum 86.53 USD
Fair Price DCF 552.46 USD

MET Dividends

Dividend Yield 12m 2.67%
Yield on Cost 5y 5.06%
Annual Growth 5y 3.43%
Payout Consistency 32.0%

MET Growth Ratios

Growth Correlation 3m 15%
Growth Correlation 12m 88.1%
Growth Correlation 5y 85.4%
CAGR 5y 13.63%
CAGR/Mean DD 5y 1.22
Sharpe Ratio 12m 1.02
Alpha -4.02
Beta 1.25
Volatility 34.36%
Current Volume 8296.5k
Average Volume 20d 3898.3k
What is the price of MET stocks?
As of December 21, 2024, the stock is trading at USD 81.36 with a total of 8,296,509 shares traded.
Over the past week, the price has changed by -1.96%, over one month by -1.50%, over three months by +1.34% and over the past year by +28.66%.
Is MetLife a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, MetLife (NYSE:MET) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.07 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MET as of December 2024 is 86.53. This means that MET is currently overvalued and has a potential downside of 6.35%.
Is MET a buy, sell or hold?
MetLife has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy MET.
  • Strong Buy: 7
  • Buy: 5
  • Hold: 2
  • Sell: 1
  • Strong Sell: 0
What are the forecast for MET stock price target?
According to ValueRays Forecast Model, MET MetLife will be worth about 95 in December 2025. The stock is currently trading at 81.36. This means that the stock has a potential upside of +16.79%.
Issuer Forecast Upside
Wallstreet Target Price 92.5 13.7%
Analysts Target Price 78.5 -3.5%
ValueRay Target Price 95 16.8%